Thursday, February 9, 2012

You are here: Home / Intellectual Property / Health Care Reform Legislation Lacks Proposed Ban on Drug Patent Settlements
Subscribe to the IP Headline RSS feed | Subscribe to the IP Headline feed via Email

Health Care Reform Legislation Lacks Proposed Ban on Drug Patent Settlements

March 26, 2010 in Patent Trademark & Copyright Journal · Leave a Comment 

The $940 billion previous hithealthnext hit previous hitcarenext hit measure passed March 21 by the House does not include a ban on so-called pay-for-delay patent case settlements between branded and generic drug companies. The Reconciliation Act of 2010 (H.R. 4872) now moves to the Senate.

  1. Read this entire article for free, simply activate your free 15 day trial access to Patent Trademark & Copyright Journal now.
Patent Trademark & Copyright Journal
  3. (required)
  4. (required)
  5. (valid email required)
  6. (required)
  7. (required)
  8. (required)
  10. (required)
  11. (required)
  12. (required)
  13. (required)
  14. Captcha
 

cforms contact form by delicious:days

Filed under Intellectual Property · Tagged with , , ,

Comments

Please feel free to comment on this article...
You can obtain a picture to go with your comment at gravatar!